Mdt-15
Sciatica
Medtronic Spinal and BiologicsPhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
19 Active assets in the Sciatica cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LIDOCAINE C.L.A.Vleggeert-Lankamp | Phase 4 | BBB |
DEXAMETHASONE University of Miami | Phase 4 | BBB |
NEPENTHE Akdeniz University | Phase 4 | BB |
Naproxen Ostfold Hospital Trust | Phase 4 | BB |
(RS)-KETOPROFEN University Hospital, Grenoble | Phase 4 | BB |
View all 45 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →